Brinavess
NICE to appraise hep C drugs Victrelis and telaprevir
May 26, 2011Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir
NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
Merck wins double approval in Europe
September 3, 2010Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme
European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …
Novel anticoagulants set to lead atrial fibrillation market
July 9, 2010Sales and Marketing Brinavess, Multaq, Pradaxa, Xarelto, apixaban, atrial fibrilation
Novel anticoagulants set to capture the atrial fibrillation market by 2019, according to a new report. Analysts Decision Resources say …
Shire’s Vpriv recommended for European approval
June 28, 2010Sales and Marketing Brinavess, Gaucher, Rapiscan, Ruconest, Shire, Sycrest
Shire has won backing from a key European regulatory committee for its new Gaucher disease orphan drug. Vpriv was one …
Merck’s Brinavess performs in phase III
May 18, 2010Research and Development Brinavess, Merck & Co, atrial fibrilation
Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …
